You just read:

Seattle Genetics Highlights Vadastuximab Talirine (SGN-CD33A) Data in Acute Myeloid Leukemia (AML) at the 21st Congress of the European Hematology Association

News provided by

Seattle Genetics, Inc.

11 Jun, 2016, 02:30 ET